Search

Filters
Clear All
  • 14
  • 48
  • 625

Phase

  • 12
  • 16
  • 58
  • 8
  • 73
  • 4
  • 507
  • 607
  • 283
  • 674
  • 13

Found 687 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

G
Greg Durm, MD
18 years - 100 years
All genders
Phase 2
Interventional
The purpose of this study is to compare two treatment approaches that are currently used after surgery for head and neck cancer. One approach is to administer radiation therapy alone. A second approach is to administer radiation therapy along with the chemotherapy drug, cisplatin.
M
Monika Fischer, MD
18 years - 65 years
All genders
Phase 3
Interventional
What is the purpose of this study?The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the bowel compared to vedolizumab only (also called monotherapy) in adults with moderately or severely active …
R
Raj Vuppalanchi, MD
18 years - 80 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on people with non-cirrhotic NASH (Nonalcoholic Steatohepatitis) or MASH (Metabolic Dysfunction-Associated Steatohepatitis) and fibrosis. NASH and MASH are conditions where fat builds up in the liver, causing inflammation and damage. The purpose of this study is to see if the investigational …
 Vape Study: Help us Understand Nicotine Dependence with Brain Stimulation
J
Joshua Brown
21 years - 50 years
Accepts healthy volunteer
All genders
Do you use nicotine-based vapes? Our study is testing the effects of brain stimulation on nicotine use and craving. Temporal interference (TI) delivers very mild electrical currents to the scalp that reach deeper brain regions linked to addiction, without surgery. You may qualify to be in this study if you:Are between the …
J
Julie Clary, MD
18 years - 100 years
All genders
Phase 3
Interventional
This study investigates the effect of an investigational medication on reducing major adverse cardiovascular events in adults with high levels of lipoprotein(a), a substance in the blood linked to heart disease. People with high lipoprotein(a) may have had a heart attack, stroke, or other heart-related issues, or be at risk …
J
Jennifer King
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?Subjects with cT2-T3N0M0 urothelial cancer of the bladder will be enrolled. After completingwo cycles of pembrolizumab, subjects will undergo a restaging MRI of the abdomen and pelvis with a standard acquisition protocol (as outlined in the protocol) as well as CT chest. A CThe …
R
Rohan Maniar
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-small cell lung cancer. Amivantamab-SC is a drug that reduces extra copies of the MET gene, a change present in your tumor. Giving amivantamab-SC …
J
John Fuqua, MD
3 years - 11 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on children with Noonan syndrome, Turner syndrome, and SHOX deficiency who have not grown adequately during or after treatment with human growth hormone. The purpose of this study is to evaluate how three different doses of the investigational medication affect growth …
M
Misty D. Shields, MD, PhD
18 years - 100 years
All genders
This study investigates the use of an investigational medication compared to durvalumab for people with limited-stage small-cell lung cancer (SCLC). Small-cell lung cancer is a type of cancer that starts in the lungs and is known for growing quickly. Participants in this study have already received chemotherapy and radiotherapy, which …
S
Sherif Farag, MD
All genders
Observational
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and otherdications.
671 - 680 of 687